, Comprendre Le cancer, qu'est-ce que c'est ? | Thierry Souccar Editions

. Cancer and . Disponible,

L. N. Disponible,

A. M. Bondia, N. Larcher, L. Garrelly, J. C. Rossi, and R. Pascal, Synthesis and ligation ability of monoaminooxy-functionalized dendrigraft poly-l-lysine (DGL), Tetrahedron Letters. juin, vol.2010, issue.25, pp.3330-3333

. Pamam-dendrimers and . Disponible,

G. Bozzuto and A. Molinari, Liposomes as nanomedical devices, Int. J. Nanomedicine, vol.2, issue.2015, pp.975-999

A. Saupe, K. C. Gordon, and T. Rades, Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy, Int. J. Pharm, vol.314, issue.1, pp.56-62, 2006.

M. Wu and S. Huang, Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment, Mol. Clin. Oncol, vol.7, issue.5, pp.738-746, 2017.

D. Closa, Los desafios de la Ciencia. La nanomedicina, 2017.

F. Arcamone, G. Cassinelli, G. Fantini, A. Grein, P. Orezzi et al., Peucetius var. caesius. Biotechnology and Bioengineering, vol.11, issue.6, p.14, 1969.

A. Gallani, Etude du profil de sécurité des specialités à base de doxorubicine : influence de la forme galénique, 2016.

P. P. Wibroe, D. Ahmadvand, M. A. Oghabian, A. Yaghmur, and S. M. Moghimi, An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome, Journal of Controlled Release, vol.221, pp.1-8, 2016.

J. Lin, S. Shigdar, D. Z. Fang, D. Xiang, M. Q. Wei et al., Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model, PLoS One, vol.9, issue.7, 2014.

P. J. Gaillard, C. Appeldoorn, R. Dorland, J. Van-kregten, F. Manca et al., Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101), PLoS One, vol.9, issue.1, 2014.

A. Gabizon, H. Shmeeda, and Y. Barenholz, Pharmacokinetics of Pegylated Liposomal Doxorubicin, Clin. Pharmacokinet, vol.42, issue.5, pp.419-436, 2003.

K. Shao, . Hou, W. Duan, . Go, and K. P. Wong, Intracellular drug delivery by sulfatidemediated liposome to gliomas, J. Control. Release, vol.115, issue.2, pp.150-157, 2006.

S. P. Kuruvilla, G. Tiruchinapally, A. C. Crouch, M. Elsayed, and J. M. Greve, Dendrimerdoxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicininduced cardiotoxicity in a murine hepatocellular carcinoma model, PLoS One, vol.12, issue.8, 2017.

J. F. Blanc, J. C. Barbare, A. S. Baumann, V. Boige, K. Boudjema et al., Thésaurus National de Cancérologie Digestive, 2017.

J. Shen, X. Li, L. Fan, X. Zhou, J. Han et al., Heterogeneous dimer peptideconjugated polylysine dendrimer-Fe3O4 composite as a novel nanoscale molecular probe for early diagnosis and therapy in hepatocellular carcinoma, Int. J. Nanomedicine, vol.12, 2017.

L. Han, M. Liu, D. Ye, N. Zhang, E. Lim et al., Tumor cell membrane-targeting pHdependent electron donor-acceptor fluorescence systems with low background signals. Biomaterials, 1 mars, vol.35, 2014.

X. Sun, Y. Li, T. Liu, Z. Li, X. Zhang et al., Peptide-based imaging agents for cancer detection, Adv. Drug. Deliv. Rev, pp.110-111, 2017.

B. Chen, S. Cao, Y. Zhang, X. Wang, J. Liu et al., A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy, BMC Cell Biol, vol.10, p.63, 2009.

M. Mahmoudi, S. Sant, B. Wang, S. Laurent, and T. Sen, Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy, Advanced Drug Delivery Reviews, vol.63, issue.1, pp.24-46, 2011.

M. M. Gottesman, T. Fojo, and S. E. Bates, Multidrug resistance in cancer: role of ATP-dependent transporters, Nat. Rev. Cancer, vol.2, issue.1, pp.48-58, 2002.

G. Hu, H. Zhang, L. Zhang, S. Ruan, Q. He et al., Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment, Int. J. Pharm, vol.496, issue.2, pp.1057-1068, 2015.

T. Wei, C. Chen, J. Liu, C. Liu, P. Posocco et al., Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance, vol.112, pp.2978-2983, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01131206

R. Roy, J. Yang, and M. A. Moses, Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer, J. Clin. Oncol, vol.27, issue.31, pp.5287-5297, 2009.

G. Hu, X. Chun, Y. Wang, Q. He, and H. Gao, Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment, Oncotarget, vol.6, issue.38, pp.41258-41274, 2015.

G. Cinar, A. Ozdemir, S. Hamsici, G. Gunay, A. Dana et al., Local delivery of doxorubicin through supramolecular peptide amphiphile nanofiber gels, Biomaterials Science, vol.5, issue.1, pp.67-76, 2017.

Y. Bae and K. Kataoka, Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers, Advanced Drug Delivery Reviews, issue.10, pp.768-784, 2009.

S. Lv, M. Li, Z. Tang, W. Song, H. Sun et al., Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy, Acta Biomaterialia, issue.9, pp.9330-9342, 2013.

. Sigma-aldrich,

C. G. Alves, R. Lima-sousa, D. De-melo-diogo, R. O. Louro, and I. J. Correia, IR780 based nanomaterials for cancer imaging and photothermal, photodynamic and combinatorial therapies, International Journal of Pharmaceutics, vol.5, issue.1, pp.164-175, 2018.

C. Jiang, H. Cheng, A. Yuan, X. Tang, J. Wu et al., Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy, Acta Biomaterialia, vol.14, pp.61-69, 2015.

H. Maeda, J. Fang, T. Inutsuka, Y. Et, and . Kitamoto, Vascular Permeability Enhancement in Solid Tumor: Various Factors, Mechanisms Involved and Its Implications, International Immunopharmacology, vol.3, issue.3, pp.319-328, 2003.

S. Lin, R. Huang, W. Liao, C. Chuang, and C. Chang, Multifunctional PEGylated Albumin/IR780/Iron Oxide Nanocomplexes for Cancer Photothermal Therapy and MR Imaging, Nanotheranostics, vol.2, issue.2, pp.106-116, 2018.

S. Li, J. Johnson, A. Peck, and Q. Xie, Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles, J. Transl. Med, 2017.

X. Yang, H. Li, C. Qian, Y. Guo, C. Li et al., Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and Photothermal therapy, Nanomedicine: Nanotechnology, Biology and Medicine, vol.14, issue.7, pp.2283-2294, 2018.

E. Raymond, L. Dahan, J. Raoul, Y. Bang, I. Borbath et al., Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors, New England Journal of Medicine, vol.364, issue.6, pp.501-513, 2011.

T. F. Chu, M. A. Rupnick, R. Kerkela, S. M. Dallabrida, D. Zurakowski et al., Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. The Lancet, 15 déc, vol.370, pp.2011-2019, 2007.

J. Choi, E. Rustique, M. Henry, M. Guidetti, V. Josserand et al., Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR dye: In vitro and in vivo evaluation, International Journal of Pharmaceutics, vol.532, issue.2, pp.677-685, 2017.

Y. Kuang, K. Zhang, Y. Cao, X. Chen, K. Wang et al., Hydrophobic IR-780 Dye Encapsulated in cRGD-Conjugated Solid Lipid Nanoparticles for NIR Imaging-Guided Photothermal Therapy, ACS Appl. Mater. Interfaces, vol.12, issue.2017, pp.12217-12226

H. Li, K. Wang, X. Yang, Y. Zhou, Q. Ping et al., Dual-function nanostructured lipid carriers to deliver IR780 for breast cancer treatment: Anti-metastatic and photothermal anti-tumor therapy, Acta Biomaterialia, vol.53, pp.399-413, 2017.

H. Li, X. Yang, Z. Zhou, K. Wang, C. Li et al., Near-infrared light-triggered drug release from a multiple lipid carrier complex using an all-in-one strategy, Journal of Controlled Release, vol.261, pp.126-137, 2017.

G. Chen, K. Wang, Y. Zhou, L. Ding, A. Ullah et al., Oral Nanostructured Lipid Carriers Loaded with Near-Infrared Dye for Image-Guided Photothermal Therapy, ACS Appl

. Mater and . Interfaces, , vol.8, 2016.

S. K. Rajendrakumar, N. Chang, A. Mohapatra, S. Uthaman, B. Lee et al., A Lipophilic IR-780 Dye-Encapsulated Zwitterionic Polymer-Lipid Micellar Nanoparticle for Enhanced Photothermal Therapy and NIR-Based Fluorescence Imaging in a Cervical Tumor Mouse Model, Int. J. Mol. Sci, vol.13, issue.4, 2018.

A. Yuan, X. Qiu, X. Tang, W. Liu, J. Wu et al., Self-assembled PEG-IR-780-C13 micelle as a targeting, safe and highly-effective photothermal agent for in vivo imaging and cancer therapy, Biomaterials, vol.51, pp.184-193, 2015.

X. Qiu, L. Xu, Y. Zhang, A. Yuan, K. Wang et al., Photothermal Ablation of in Situ Renal Tumor by PEG-IR780-C13 Micelles and Near-Infrared Irradiation, Mol. Pharmaceutics, vol.13, issue.3, pp.829-838, 2016.

L. Yan, H. Wang, A. Zhang, C. Zhao, Y. Chen et al., Bright and Stable Near-Infrared Pluronic-Silica Nanoparticles as a Contrast Agent for in vivo Optical Imaging, J. Mater. Chem. B Mater. Biol. Med, vol.4, issue.33, pp.5560-5566, 2016.

J. Peng, Y. Xiao, W. Li, Q. Yang, L. Tan et al., Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy, Adv. Sci, vol.26, issue.5, 2018.

, NLG-919 (CAS 1402836-58-1) | Cayman Chemical

Z. Yang, R. Cheng, C. Zhao, N. Sun, H. Luo et al., Thermo-and pH-dual responsive polymeric micelles with upper critical solution temperature behavior for photoacoustic imaging-guided synergistic chemo-photothermal therapy against subcutaneous and metastatic breast tumors, Theranostics, vol.16, issue.15, 2018.

Z. Li, H. Wang, Y. Chen, Y. Wang, H. Li et al., pH-and NIR Light-Responsive Polymeric Prodrug Micelles for Hyperthermia-Assisted Site-Specific Chemotherapy to Reverse Drug Resistance in Cancer Treatment, Small, vol.12, issue.20, 2016.

A. Jezierska and T. Motyl, Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review, Med. Sci. Monit, vol.15, issue.2, pp.32-40, 2009.

, Présentation de l'IRM : principe et fonctionnement de l'IRM sur chimie sup. Disponible sur

F. Lux, L. Sancey, A. Bianchi, Y. Crémillieux, S. Roux et al., Gadolinium-based nanoparticles for theranostic MRI-radiosensitization, Nanomedicine, vol.10, issue.11, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01275075

J. Ramalho, M. Ramalho, M. Jay, L. M. Burke, and R. C. Semelka, Gadolinium toxicity and treatment, Magn. Reason. Imaging, vol.34, issue.10, 2016.

L. Duc, G. Roux, S. Paruta-tuarez, A. Dufort, S. Brauer et al., Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment, Cancer Nanotechnol, issue.1, p.5, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01115650

L. Duc, G. Miladi, I. Alric, C. Mowat, P. Bräuer-krisch et al., Toward an Image-Guided Microbeam Radiation Therapy Using Gadolinium-Based Nanoparticles, ACS Nano, vol.5, issue.12, pp.9566-9574, 2011.

A. Mignot, C. Truillet, F. Lux, L. Sancey, C. Louis et al., A Top-Down Synthesis Route to Ultrasmall Multifunctional Gd-Based Silica Nanoparticles for Theranostic Applications, Chemistry -A European Journal, vol.19, issue.19, pp.6122-6136, 2013.

F. Lux, A. Mignot, P. Mowat, C. Louis, S. Dufort et al., Ultrasmall Rigid Particles as Multimodal Probes for Medical Applications, Angewandte Chemie International Edition, vol.50, issue.51, pp.12299-12303, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00658275

A. Detappe, E. Thomas, M. W. Tibbitt, S. Kunjachan, O. Zavidij et al., Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance-Computed Tomography Image Guided Radiation Therapy, Nano Lett, vol.17, issue.3, pp.1733-1740, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01689566

S. Dufort, L. Duc, G. Salomé, M. Bentivegna, V. Sancey et al., The High Radiosensitizing Efficiency of a Trace of Gadolinium-Based Nanoparticles in Tumors, Sci. Rep, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01405772

F. Lux, L. Sancey, A. Bianchi, Y. Crémillieux, S. Roux et al., Gadolinium-based nanoparticles for theranostic MRI-radiosensitization, Nanomedicine, vol.10, issue.11, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01275075

R. Serduc, Effets de la radiothérapie par microfaisceaux synchrotron sur la microvascularisation cérébrale saine et tumorale chez la souris, 2006.

F. Lux, V. L. Tran, E. Thomas, S. Dufort, F. Rossetti et al., AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine, BJR, p.92, 1093.
URL : https://hal.archives-ouvertes.fr/hal-01935540

L. Sancey, F. Lux, S. Kotb, S. Roux, S. Dufort et al., The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy, Br. J. Radiol, p.87, 1041.
URL : https://hal.archives-ouvertes.fr/hal-01286747

F. Lux, A. Detappe, S. Dufort, L. Sancey, C. Louis et al., Nanoparticules ultrafines en radiothérapie : le cas des AGuIX, Cancer/Radiothérapie, vol.19, issue.6, pp.508-514, 2015.

A. Bianchi, S. Dufort, F. Lux, P. Fortin, N. Tassali et al., Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents, Proc. Natl. Acad. Sci. USA, 24 juin, vol.111, pp.9247-9252, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01115890

F. Lux, V. L. Tran, E. Thomas, S. Dufort, F. Rossetti et al., AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine, BJR, p.92, 1093.
URL : https://hal.archives-ouvertes.fr/hal-01935540

P. Gimenez, Radiotherapy by photoactivation of nanoparticles and Mössbauer effect

L. ?tefan?íková, S. Lacombe, D. Salado, E. Porcel, E. Pagá?ová et al., Effect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cells, J. Nanobiotechnology, vol.14, p.92, 1093.

L. Sancey, S. Kotb, C. Truillet, F. Appaix, A. Marais et al., Long-Term in Vivo Clearance of Gadolinium-Based AGuIX Nanoparticles and Their Biocompatibility after Systemic Injection, ACS Nano, vol.9, issue.3, pp.2477-2488, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01207383

B. Wu, S. Lu, H. Yu, R. Liao, H. Li et al., Gadolinium-chelate functionalized bismuth nanotheranostic agent for in vivo MRI/CT/PAI imaging-guided photothermal cancer therapy, Biomaterials, mars, vol.159, pp.37-47, 2018.

J. Li, S. Huang, K. Shao, Y. Liu, S. An et al., A choline derivate-modified nanoprobe for glioma diagnosis using MRI, Sci. Rep, vol.8, issue.2013

W. Debinski, D. M. Gibo, S. W. Hulet, J. R. Connor, and G. Y. Gillespie, Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas, Clin. Cancer Res, vol.5, issue.5, pp.985-990, 1999.

M. Witusik-perkowska, M. Zakrzewska, and M. Szybka, Astrocytoma-associated antigens -IL13Ralpha2, Fra-1, and EphA2 as potential markers to monitor the status of tumourderived cell cultures in vitro, Cancer Cell Int, vol.14, p.82, 2014.

X. Liu, A. B. Madhankumar, P. A. Miller, K. A. Duck, S. Hafenstein et al., MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA, Neuro Oncol, vol.18, issue.5, pp.691-699, 2016.

Y. Jin, N. Zhang, C. Li, K. Pu, C. Ding et al., Nanosystem composed with MSNs, gadolinium, liposome and cytotoxic peptides for tumor theranostics, Colloids Surf. B Biointerfaces, vol.151, pp.240-248, 2017.

Z. Zha, Z. Deng, Y. Li, C. Li, J. Wang et al., Biocompatible polypyrrole nanoparticles as a novel organic photoacoustic contrast agent for deep tissue imaging, Nanoscale, issue.5, pp.4462-4467, 2013.

S. Ray, Z. Li, C. Hsu, L. Hwang, Y. Lin et al., Dendrimer-and copolymer-based nanoparticles for magnetic resonance cancer theranostics, vol.8, pp.6322-6349, 2018.

D. Lipsitz, Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs, Vet. Pathol, 2003.

M. Filippi, V. Catanzaro, D. Patrucco, M. Botta, L. Tei et al., First in vivo MRI study on theranostic dendrimersomes, Journal of Controlled Release, vol.248, pp.45-52, 2017.

J. Zhu, Z. Xiong, and M. Shen, Encapsulation of doxorubicin within multifunctional gadolinium-loaded dendrimer nanocomplexes for targeted theranostics of cancer cells, RSC Adv, vol.5, issue.38, pp.30286-30296, 2015.

M. Tan, Z. Ye, D. Lindner, S. M. Brady-kalnay, and Z. Lu, Synthesis and Evaluation of a Targeted Nanoglobular Dual-Modal Imaging Agent for MR Imaging and Image-Guided Surgery of Prostate Cancer, Pharm. Res., juin, vol.2014, issue.6, pp.1469-1476

, La chirurgie des glioblastomes et des gliomes malins ou bas grade. Disponible sur